Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Adult Leukemia Clinical Trials and Research

  • New Patient Appointments

    Make Appointment Online
    Dana-Farber/Brigham and Women's Cencer Center logo
    US News adult badge - smaller
  • Clinical Trials Questions?



  • Marlise Luskin, MD, MSCE, a specialist in the Adult Leukemia Program at Dana-Farber Cancer Institute, explains an innovative trial that combines venetoclax with chemotherapy for older patients with ALL. Learn more about this study.